On the objectivity, reliability, and validity of deep learning enabled bioimage analyses

Abstract

Bioimage analysis of fluorescent labels is widely used in the life sciences. Recent advances in deep learning (DL) allow automating time-consuming manual image analysis processes based on annotated training data. However, manual annotation of fluorescent features with a low signal-to-noise ratio is somewhat subjective. Training DL models on subjective annotations may be instable or yield biased models. In turn, these models may be unable to reliably detect biological effects. An analysis pipeline integrating data annotation, ground truth estimation, and model training can mitigate this risk. To evaluate this integrated process, we compared different DL-based analysis approaches. With data from two model organisms (mice, zebrafish) and five laboratories, we show that ground truth estimation from multiple human annotators helps to establish objectivity in fluorescent feature annotations. Furthermore, ensembles of multiple models trained on the estimated ground truth establish reliability and validity. Our research provides guidelines for reproducible DL-based bioimage analyses.

Data availability

Official repository of our study "On the objectivity, reliability, and validity of deep learning enabled bioimage analyses" can be found at Dryad (https://doi.org/10.5061/dryad.4b8gtht9d). In addition, we also provide all code in our GitHub repository (https://github.com/matjesg/bioimage_analysis).

The following data sets were generated

Article and author information

Author details

  1. Dennis Segebarth

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3806-9324
  2. Matthias Griebel

    Department of Business and Economics, University of Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1959-0242
  3. Nikolai Stein

    Department of Business and Economics, University of Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Cora R von Collenberg

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Corinna Martin

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Dominik Fiedler

    Institute of Physiology, Westfälische Wilhlems-Universität, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Lucas B Comeras

    Department of Pharmacology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  8. Anupam Sah

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  9. Victoria Schoeffler

    Department of Child and Adolescent Psychiatry, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Teresa Lüffe

    Department of Child and Adolescent Psychiatry, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Alexander Dürr

    Department of Business and Economics, University of Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Rohini Gupta

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Manju Sasi

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Christina Lillesaar

    Department of Child and Adolescent Psychiatry, University Hospital Würzburg, Würzburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5166-2851
  15. Maren D Lange

    Institute of Physiology, Westfälische Wilhlems-Universität, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Ramon O Tasan

    Department of Pharmacology, University of Inssbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  17. Nicolas Singewald

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0166-3370
  18. Hans-Christian Pape

    Institute of Physiology, Westfälische Wilhlems-Universität, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6874-8224
  19. Christoph M Flath

    Department of Business and Economics, University of Würzburg, Würzburg, Germany
    For correspondence
    christoph.flath@uni-wuerzburg.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1761-9833
  20. Robert Blum

    Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
    For correspondence
    Blum_R@ukw.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5270-3854

Funding

Deutsche Forschungsgemeinschaft (ID 44541416 - TRR58,A10)

  • Robert Blum

Deutsche Forschungsgemeinschaft (ID 44541416 - TRR58,A03)

  • Hans-Christian Pape

Deutsche Forschungsgemeinschaft (ID 44541416 - TRR58,B08)

  • Maren D Lange

Graduate School of Life Sciences Wuerzburg (fellowship)

  • Rohini Gupta
  • Manju Sasi

Austrian Science Fund (P29952 & P25851)

  • Ramon O Tasan

Austrian Science Fund (I2433-B26,DKW-1206,SFB F4410)

  • Nicolas Singewald

Interdisziplinaeres Zentrum fuer Klinische Zusammenarbeit Wuerzburg (N-320)

  • Christina Lillesaar

Deutsche Forschungsgemeinschaft (ID 424778381)

  • Robert Blum

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All effort was taken to minimize the number of animals used and their suffering.Lab-Wue1: All experiments with C57BL/6J wildtype mice were in accordance with the Guidelines set by the European Union and approved by our institutional Animal Care, the Utilization Committee and the Regierung von Unterfranken, Würzburg, Germany (License number: 55.2-2531.01-95/13). C57BL/6J wildtype mice were bred in the animal facility of the Institute of Clinical Neurobiology, University Hospital of Würzburg, Germany.Lab Mue: Male All animal experiments with male C57Bl/6J mice (Charles River, Sulzfeld, Germany) were carried out in accordance with European regulations on animal experimentation and protocols were approved by the local authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen).Lab-Inns1: Experiments were performed in adult, male C57Bl/6NCrl mice (Charles River, Sulzfeld, Germany). They were bred in the Department of Pharmacology at the Medical University Innsbruck, Austria. All procedures involving animals and animal care were conducted in accordance with international laws and policies (Directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 2011) and were approved by the Austrian Ministry of Science.Lab-Inns2: Male 129S1/SvImJ (S1) mice (Charles River, Sulzfeld, Germany) were used for experimentation. The Austrian Animal Experimentation Ethics Board (Bundesministerium für Wissenschaft Forschung und Wirtschaft, Kommission für Tierversuchsangelegenheiten) approved all experimental procedures.

Copyright

© 2020, Segebarth et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,623
    views
  • 512
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dennis Segebarth
  2. Matthias Griebel
  3. Nikolai Stein
  4. Cora R von Collenberg
  5. Corinna Martin
  6. Dominik Fiedler
  7. Lucas B Comeras
  8. Anupam Sah
  9. Victoria Schoeffler
  10. Teresa Lüffe
  11. Alexander Dürr
  12. Rohini Gupta
  13. Manju Sasi
  14. Christina Lillesaar
  15. Maren D Lange
  16. Ramon O Tasan
  17. Nicolas Singewald
  18. Hans-Christian Pape
  19. Christoph M Flath
  20. Robert Blum
(2020)
On the objectivity, reliability, and validity of deep learning enabled bioimage analyses
eLife 9:e59780.
https://doi.org/10.7554/eLife.59780

Share this article

https://doi.org/10.7554/eLife.59780

Further reading

    1. Computational and Systems Biology
    George N Bendzunas, Dominic P Byrne ... Natarajan Kannan
    Research Article

    In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.